InsightRx - About the company
InsightRx is a series A company based in San Francisco (United States), founded in 2015 by Ranvir Mangat, Ron Keizer and Sirj Goswami. It operates as an Analytics platform for precision dosing. InsightRx has raised $13.2M in funding from investors like OSF HealthCare, GreatPoint Ventures and HealthX Ventures. The company has 444 active competitors, including 130 funded and 84 that have exited. Its top competitors include companies like Caris Life Sciences, MedGenome and Geneoscopy.
Company Details
InsightRX, a precision medicine company founded in 2015, offers to optimize drug dosage for the individual patient. Efforts in precision medicine, currently, focuses only on selecting the right drug for the right patient and drug dosage is overlooked. According to the company, its InsightRX software platform provides an informed patient-specific dose by leveraging machine learning, mathematical models, patient demographics, physiological characteristics, pharmacogenomic data, drug concentrations and biomarkers. The company caters to Clinical Pharmacists and Physicians and aims at reducing adverse events, improving outcomes and reducing hospital costs.
- Website
- www.insight-rx.com/
- Social
- Registered Address
- San Francisco, California
Key Metrics
Founded Year
2015
Location
San Francisco, United States
Stage
Series A
Total Funding
$13.2M in 3 rounds
Latest Funding Round
Investors
Ranked
93rd among 444 active competitors
Employee Count
32 as on Aug 31, 2026
Similar Companies
Legal entities associated with InsightRx
InsightRx is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Insight Rx Inc CIN: 20201891159 , United States, Active | Oct 16, 2020 | - | - | - |
InsightRx Inc. CIN: 11275208 , Canada, Active | Mar 06, 2019 | - | - | - |
Insight Rx, Inc. CIN: 473333269 , United States, Active | Feb 26, 2015 | - | 23 (As on Dec 31, 2024) | - |
Sign up to download InsightRx's company profile
InsightRx's funding and investors
InsightRx has raised a total funding of $13.2M over 3 rounds. Its first funding round was on May 22, 2017. Its latest funding round was a Conventional Debt round on Feb 23, 2024 for $*****. 1 investor participated in its latest round. InsightRx has 17 institutional investors.
Here is the list of recent funding rounds of InsightRx:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 23, 2024 | 4016559 | Conventional Debt | 7857126 | 8794385 | 8290495 | 2347300 |
Sep 19, 2019 | 6801211 | Series A | 9200644 | 9986751 | 9746127 | |
May 22, 2017 | 5069561 | Series A | 7568901 | 8314685 | 6499789 |
Access funding benchmarks and valuations. Sign up today!View details of InsightRx's funding rounds and investors
InsightRx's founders and board of directors
Founder? Claim ProfileHere are the details of InsightRx's key team members:
- Ranvir Mangat: COO & Co-Founder of InsightRx. Contact Info: 1 email address
- Ron Keizer: CTO & Co-Founder of InsightRx.
- Sirj Goswami: CEO & Co-Founder of InsightRx.
View details of InsightRx's Founder profiles and Board Members
InsightRx's employee count trend
InsightRx has 32 employees as of Aug 26. Here is InsightRx's employee count trend over the years:
Uncover InsightRx's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
InsightRx's Competitors and alternates
Top competitors of InsightRx include Caris Life Sciences, MedGenome and Geneoscopy. Here is the list of Top 10 competitors of InsightRx, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 71/100 | |
2nd | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 70/100 | ||
3rd | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
4th | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
5th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
6th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
7th | Regulus Therapeutics 2007, San Diego (United States), Acquired | Innovative medicines company reimagining medicine to improve and extend people’s lives | $35M | 62/100 | |
8th | GenSight Biologics 2011, Paris (France), Public | Developer of viral vector-based gene therapies for retinal neurodegenerative diseases | $76.6M | 61/100 | |
9th |  Repare Therapeutics 2016, Montreal (Canada), Acquired | Developer of targeted therapies to address the genetic alterations associated with selected tumors | $166M | 60/100 | |
10th | Dicerna Pharmaceuticals 2007, Lexington (United States), Acquired | Developer of drugs by using RNA interference technology platform | $106M | 60/100 | |
93rd |  InsightRx 2015, San Francisco (United States), Series A | Analytics platform for precision dosing | $13.2M | 43/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on InsightRx's competitors? Click here to see the top ones
InsightRx's Investments and acquisitions
InsightRx has made no investments or acquisitions yet.
Reports related to InsightRx
Here is the latest report on InsightRx's sector:
News related to InsightRx
Filter this list•
Northern Arizona Healthcare Partners with InsightRX on the First Commercial Precision Dosing Model for HeparinPR Newswire•Jun 14, 2024•InsightRx, Northern Arizona Healthcare
•
InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific BreakthroughsPR Newswire•May 14, 2024•InsightRx
•
CIBC Innovation Banking Provides Growth Capital to Drips Holdings, LLCFinancial Post•Feb 28, 2024•Drips Marketing, Canadian Imperial Bank of Commerce, InsightRx
•
InsightRX Provides Máxima Medical Center with Precision Dosing GuidancePR Newswire•Dec 13, 2022•InsightRx
•
InsightRX Precision Medicine Software Platform Selected by Amsterdam UMCAiThority•Jul 26, 2022•Amsterdam UMC, InsightRx
•
InsightRX Precision Medicine Technology To Help Improve Care For Patients Receiving Stem Cell TransplantsAiThority•Nov 23, 2021•InsightRx
•
Sage Growth Partners Selected by InsightRX for Strategic Marketing CommunicationsPR Newswire•Jan 14, 2020•Sage Growth Partners, InsightRx
•
InsightRX, Premier Partner to Bring Precision Antibiotic Dosing to 4,000 HospitalsHIT Consultant•Nov 13, 2019•InsightRx, Premier
•
InsightRX Welcomes Two New Expert Specialists to Its Expanding TeamPR Newswire•Sep 26, 2019•InsightRx, Vivify Health
•
Precision medication dosing tool InsightRX closes $10MMobiHealthNews•Sep 19, 2019•InsightRx, HealthX Ventures, Rock Health, Leawood Venture Capital and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about InsightRx
Explore our recently published companies
- Way - Helsinki based, 2024 founded, Seed company
- Delite - Hyderabad based, 2010 founded, Unfunded company
- Yuki - Tel Aviv based, 2023 founded, Seed company
- Hedgepointcapital.com - 2021 founded, Funding Raised company
- MicroRoboTech - Hangzhou based, 2025 founded, Series A company
- Semper Plugins - Durham based, 2011 founded, Acquired company
